Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Masimo Corp (NQ: MASI )

174.42 +0.28 (+0.16%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 23, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 197,280
Open 175.01
Bid (Size) 171.35 (1)
Ask (Size) 177.81 (1)
Prev. Close 174.14
Today's Range 172.74 - 175.99
52wk Range 108.89 - 184.97
Shares Outstanding 52,500,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Masimo Announces Changes to Governance Structure and Practices
From Masimo Corporation
Via Business Wire
European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring
From Masimo
Via Business Wire

Performance

YTD
+19.44%
+19.44%
1 Month
+8.41%
+8.41%
3 Month
+16.46%
+16.46%
6 Month
+22.47%
+22.47%
1 Year
+13.54%
+13.54%

More News

Read More
New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery
From Masimo
Via Business Wire
Expert Ratings for Masimo
Via Benzinga
The Latest Analyst Ratings for Masimo
Via Benzinga
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
From Masimo
Via Business Wire
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients
From Masimo
Via Business Wire
$300B California Teachers Pension Fund Joins Politan Capital In Legal Action Against Masimo CEO's Employment Agreement
Via Benzinga
CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO’s Employment Agreement
From Politan Capital Management
Via Business Wire
Masimo to Present in 44th Annual Raymond James Institutional Investors Conference
From Masimo
Via Business Wire
Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results
From Masimo
Via Business Wire
Analyst Says This MedTech Giant Stock Offers 'Too Much Optionality,' Upgrades Rating
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
Via Benzinga
New Study Evaluates the Utility of Masimo ORi™ in Reducing Hyperoxemia During Laparoscopic Gastrectomy
From Masimo
Via Business Wire
Masimo Centroid® Receives Innovative Technology Designation from Vizient
From Masimo
Via Business Wire
Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28
From Masimo
Via Business Wire
Thoughts For Thursday: Risk-off, Risk-on
Via Talk Markets
NeurAxis: Should You Buy This IPO?
Via Talk Markets
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
From Masimo
Via Business Wire
Intuitive Surgical Stock Hits 80-Plus Relative Strength Rating Benchmark
Via Investor's Business Daily
InMode Stock Glowing Again As Cosmetic Surgery Market Recovers
Via Investor's Business Daily
Researchers Harness the Power of Masimo Root®’s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery
From Masimo
Via Business Wire
Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1™ Watch
From Masimo
Via Business Wire
How Masimo Is Taking On Electronics Giant Apple — And Winning
Via Investor's Business Daily
Apple Watch Faces Potential Import Ban As US Judge Rules Against Tech Giant In Patent Infringement Case
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.